Flightpath Biosciences
Berkeley
About Flightpath Biosciences
Flightpath Biosciences is a biotechnology company that develops medications to treat rare infectious diseases. The company is bridging scientific unknowns by interrogating disparate fields of biology, taking risks, innovating, and deploying potentially orthogonal approaches to achieve desired outcomes. It is working with leading scientists, therapeutics, and diagnostics experts across multiple scientific disciplines within several esteemed academic institutions and government agencies to create novel, targeted solutions. The company was founded in 2019 and is based in Berkeley, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $9.2M
- Funding stage: Early Stage Venture
- Last round: Seed (Feb 2023)
- Website: flightpath.bio
- Phone: 415-530-1828
Industries & Categories
Biotechnology, Health Care, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/flightpath-biosciences-108390 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.